<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00325559</url>
  </required_header>
  <id_info>
    <org_study_id>1122</org_study_id>
    <nct_id>NCT00325559</nct_id>
  </id_info>
  <brief_title>The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus</brief_title>
  <official_title>The Effect of Hyperglycaemia on Local Energy Stores in the Working Muscle in Patients With Type 1 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <brief_summary>
    <textblock>
      This study aims at investigating the effect of hyperglycaemia on physical performance and
      local energy stores in the muscle in patients with type 1 diabetes mellitus under exercise
      conditions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2006</start_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Paired difference in the time to complete a time trial corresponding to 5 km cycling between euglycaemia and hyperglycaemia</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle glycogen content during exercise in the working muscle (pre test vs. post test), in euglycaemia and hyperglycaemia respectively (All following endpoints are paired differences (euglycaemia vs. hyperglycaemia) of paired differences (pre</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IMCL content during exercise in the working muscle</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of appearance of glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of disappearance of glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of glucose infusion</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total glucose oxidation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidation of endogenous glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidation of exogenous glucose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fat oxidation (calculated via tracer and via RER)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of perceived exertion</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum lactate levels during the exercise test</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amino acid oxidation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum free fatty acid concentration</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum insulin levels</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum glucose levels</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to achieve hyperglycemia during clamp</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pretest diary data</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Diabetes Mellitus, Type 1</condition>
  <condition>Exercise</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Normoinsulinemic eu- or hyperglycemic clamp</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  Aged from 20 to 40 years

          -  Patients with type 1 diabetes mellitus lasting for at least 5 years (C-Peptide ≤ 0.3
             nmol/l in the presence of a plasma glucose level ≥ 7 mmol/L, indicating insulin
             dependence)

          -  Insulin delivery by CSII (continuous subcutaneous insulin infusion) for at least 6
             months

          -  Acceptable to good metabolic control, reflected by an HbA1c 5-8%

          -  Normal insulin sensitivity, reflected by a daily insulin requirement of 0.3-1.0 U/kg
             body weight

          -  minimum 30' of moderate exercise 3 times per week

          -  BMI in the range of 18-25 kg/m2

        Exclusion Criteria:

          -  Chronic complications of diabetes:

               -  Microalbuminuria (Mogensen nephropathy stadium ≥ III)

               -  Sensory neuropathy (vibration better than 5/8 at the metatarsophalangeal
                  articulation of digitus I)

               -  Proliferating retinopathy

               -  No history of macro-vascular complications

               -  Clinically relevant autonomous neuropathy

          -  Smoking

          -  Abnormal thyroid function

          -  Major depression, psychosis and other severe personality disorders, claustrophobia

          -  Active neoplasia

          -  Contraindications to exposure to a 1.5 T magnetic field (pace-makers, osteosynthetic
             material, etc.)

          -  Abnormal liver or renal function (creatinine &gt; 130 µmol/L; ASAT and ALAT &gt; 3 times the
             upper reference limit)

          -  Excessive alcohol consumption (&gt;60g/d) or drug-abuse

          -  Refusal to give written informed consent

          -  Participation in another study

          -  Patients, who are not suitable for the study according to the study physician
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Christoph Stettler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital of Bern</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Endocrinology, Diabetes and Clinical Nutrition, University Hospital</name>
      <address>
        <city>Bern</city>
        <zip>CH-3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2006</study_first_submitted>
  <study_first_submitted_qc>May 12, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 15, 2006</study_first_posted>
  <last_update_submitted>January 12, 2011</last_update_submitted>
  <last_update_submitted_qc>January 12, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 13, 2011</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
    <mesh_term>Hyperglycemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

